GKOS  valuation analysis

Basics
Name: Glaukos Corporation
Description: Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. (more)
Industry: Medical Instruments & Supplies
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 05, 2021
Market cap: $2.58B (964th)
Sales(TTM): $237.59M (1338th)
Earnings(TTM): -$82.76M (1251st)

Value
FFER: 4.15 (why)
Actual price: $56.03
FFEThis is Glaukos Corporation's the estimated price. FFEs are the denominator of the FFER ratio.: $13.50
Quantile: GKOS is very expensive given its fundamentals.
Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Glaukos Corporation
"Medical Instruments & Supplies" industry
Sales / MarketCap
Glaukos Corporation
"Medical Instruments & Supplies" industry
Book / MarketCap
Glaukos Corporation
"Medical Instruments & Supplies" industry
Equity / Assets
Glaukos Corporation
"Medical Instruments & Supplies" industry